Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015 and based in Belgium, V-Bio Ventures is a life science venture capital fund that invests in early- to mid-stage companies. The firm focuses on high growth potential in the biotech and healthcare sectors, with a particular emphasis on therapeutics. V-Bio Ventures has a preferred relationship with the VIB, a leading life science research institute in Belgium, which aids in sourcing deals and co-creating companies.
V-Bio Ventures invests in private companies with differentiated technology that addresses unmet needs, particularly in drug discovery and development. The firm targets early- to mid-stage investments, ranging from pre-seed to Series B, with a geographic focus on Europe. They seek innovative technologies that have significant societal and environmental impact potential.
V-Bio Ventures collaborates closely with the VIB to co-create companies based on VIB-derived innovations. Notable portfolio companies include Confo Therapeutics and Protealis, which are examples of their focus on impactful life sciences.
Submit through their form at https://v-bio.ventures/contact.
Yes, V-Bio Ventures often leads funding rounds, particularly in the early stages of investment.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and potential.
V-Bio Ventures manages a fund focused on early- to mid-stage investments, but specific fund size details are not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.